Showing results (71-80 of 2,918) with videos related to
Sort By:
Pageof 292
The Journal of Clinical Investigation|August 1, 1983
Mitochondrial dysfunction induced by fatty acid ethyl esters, myocardial metabolites of ethanolL G Lange, B E SobelThe Journal of Biological Chemistry|April 25, 1983
Rabbit myocardial cytosolic lysophospholipase. Purification, characterization, and competitive inhibition by L-palmitoyl carnitineR W Gross, B E SobelProceedings of the National Academy of Sciences of the United States of America|November 15, 1991
Augmentation of synthesis of plasminogen activator inhibitor type 1 by insulin and insulin-like growth factor type I: implications for vascular disease in hyperinsulinemic statesD J Schneider, B E SobelCardiology Clinics|February 1, 1987
Factors contributing to the emergence of coronary thrombolysisA J Tiefenbrunn, B E SobelBritish Heart Journal|May 1, 1983
Reduction of infarct size in patients with inferior infarction with intravenous glyceryl trinitrate. A randomised studyA S Jaffe, E M Geltman, A J Tiefenbrunn, et al.Journal of Cardiovascular Risk|October 26, 1999
A review of metabolic and cardiovascular effects of oral antidiabetic agents: beyond glucose-level loweringH Ginsberg, J Plutzky, B E SobelThrombosis and Haemostasis|October 18, 1993
Inhibition of endothelial cell expression of plasminogen activator inhibitor type-1 by gemfibrozilS Fujii, H Sawa, B E SobelJapanese Heart Journal|January 1, 1996
Persistence of balloon-induced arterial injury with hyperlipidemia despite gemfibrozilC Lundgren, B E Sobel, S FujiiThe Journal of Biological Chemistry|May 13, 1994
Inhibition of type-1 plasminogen activator inhibitor production by antisense oligonucleotides in human vascular endothelial and smooth muscle cellsH Sawa, B E Sobel, S FujiiArteriosclerosis and Thrombosis : a Journal of Vascular Biology|December 1, 1992
Augmented arterial wall expression of type-1 plasminogen activator inhibitor induced by thrombosisH Sawa, S Fujii, B E SobelPageof 292